Brellium, an AI-powered clinical compliance platform, has raised $16.7 million in Series A funding to transform how healthcare providers ensure compliance and quality of care.
The round was led by First Round Capital, Left Lane Capital, and Menlo Ventures, with participation from Digital Health Venture Partners, Kearny Jackson, Necessary Ventures, and prominent angel investors including Andrew Adams (CEO of Headway), Steve Gutentag and Demitri Karagas (Co-founders of Thirty Madison), Cory Levy (Z Fellows), and Fiat Ventures.
Also read – GoldState Music Raises $500 Mn in Strategic Funding
The funding will support Brellium’s rapid growth, product innovation, and hiring across multiple roles, as the company works toward its bold mission: raising the standard of care in the U.S. healthcare system by eliminating the opacity around clinical compliance.
Brellium provides clinical teams with a platform that automatically audits every patient visit against clinical and payer requirements. By proactively identifying documentation errors, Brellium reduces compliance risk, improves quality, and saves valuable time for healthcare providers.
“Our goal is to align payors and providers under a unified, transparent framework—helping clinics avoid common mistakes, learn from one another, and ultimately deliver better care,” the company stated.
As Brellium continues to expand, it invites mission-driven professionals to join in building a more efficient, compliant, and patient-focused healthcare ecosystem.
